Status: Recruiting
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic articular chondral or osteochondral defects of the knee.
Participants needed: 45
Trial details
Phase: Phase 3Age: 10-17Biological sex: AllType: InterventionalSponsor: Vericel CorporationUpdated: Oct 13, 2026Locations: 14
Eligibility criteria
Age 10 to 17 years at the time of planned randomization [+4]
At least 1 defect size ≥1.5 cm2 on the patella, femoral condyles and/or the troc... [+21]